d) im Bereich Corporate Communications EMEA at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

N/AIndustries

Requirements

Fortgeschrittenes Studium im Bereich Medien, PR, Journalismus, Kultur- oder Geisteswissenschaften oder einer vergleichbaren Fachrichtung
Guter Schreibstil
Idealerweise erste Erfahrungen in der Erstellung und Planung von Content für Social Media
Sicherer Umgang mit MS-Office (insbesondere PowerPoint, Word und Excel)
Sehr gute Deutsch- und Englischkenntnisse
Kreativität, Eigeninitiative, Einsatzbereitschaft und Organisationsgeschick
Praktikum/Werkstudententätigkeit auf mindestens 3 Monate

Responsibilities

Begleitung von internationalen Presse-Aktivitäten und Entwicklung eigener Kommunikationskonzepte
Unterstützung bei internationalen Kommunikationskampagnen für Mitarbeiter*innen in EMEA
Planung und Erstellung von Content für interne Kommunikationskanäle
Mitarbeit an der Planung, Erstellung und Pflege von Content für Social-Media-Kanäle
Überwachung und Auswertung der Performance sowie Ableitung von Optimierungspotenzialen
Enge Zusammenarbeit mit externen Kreativ- und PR-Agenturen
Eigenständige Übernahme kleinerer Projekte innerhalb des Teams

Skills

Social Media

Content Creation

Press Activities

MS PowerPoint

MS Word

MS Excel

Communication Planning

Performance Analysis

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free